• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测中重度卵巢过度刺激综合征患者康复时间的相关因素。

Predictive Factors for Recovery Time in Conceived Women Suffering From Moderate to Severe Ovarian Hyperstimulation Syndrome.

机构信息

Center for Reproductive Medicine, Henan Key Laboratory of Reproduction and Genetics, Henan Provincial Obstetrical and Gynecological Diseases (Reproductive Medicine) Clinical Research Center, Henan Engineering Laboratory of Preimplantation Genetic Diagnosis and Screening, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Department of Obstetrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

Front Endocrinol (Lausanne). 2022 Jun 15;13:870008. doi: 10.3389/fendo.2022.870008. eCollection 2022.

DOI:10.3389/fendo.2022.870008
PMID:35784536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9240280/
Abstract

OBJECTIVE

This study aimed to evaluate potential predictors for recovery time in pregnant patients with moderate to severe ovarian hyperstimulation syndrome (OHSS).

METHODS

A total of 424 pregnant patients with moderate to severe OHSS who underwent fertilization (IVF)/intracytoplasmic sperm injection (ICSI) were retrospectively identified. The clinical features and laboratory findings within 24 h after admission were collected. Treatment for OHSS was carried out according to standard procedures, including fluid replacement therapy, human albumin, aspirin, low-molecular-weight heparin, and paracentesis, when necessary. Patients were discharged from the hospital when the tmorning hematocrit was <40% and no obvious clinically relevant symptoms existed, such as abdominal distension, abdominal pain, and shortness of breath. Meanwhile, ultrasound indicating little pleural or abdominal effusion and biochemical abnormalities returning to normal were required. Spearman's correlation analysis was used to assess the association between the blood-related parameters and recovery time. Multiple linear regression models were used to assess the relationship between the clinical or laboratory parameters and recovery time.

RESULTS

The median recovery time of these patients was 11 days. In Spearman's correlation test, leukocytes, hemoglobin, platelets, hematocrit, creatinine, prothrombin time (PT), fibrinogen (Fib), D-dimer, and fibrinogen degradation products (FDPs) were positively correlated with recovery time. On the other hand, albumin and thrombin time (TT) were negatively correlated with recovery time. Multiple linear regression analysis showed that polycystic ovary syndrome (PCOS), hemoglobin, platelets, albumin, and Fib were significantly associated with the recovery time of patients with OHSS ( = 0.023,  < 0.001,  = 0.007,  < 0.001, and  = 0.019, respectively).

CONCLUSIONS

In pregnant patients with OHSS, PCOS and hypoalbuminemia were associated with a significantly longer recovery time. Meanwhile, the recovery time was longer when patients have high levels of hemoglobin, platelets, and Fib.

摘要

目的

本研究旨在评估中重度卵巢过度刺激综合征(OHSS)孕妇恢复时间的潜在预测因素。

方法

回顾性分析了 424 例中重度 OHSS 接受体外受精(IVF)/卵胞浆内单精子注射(ICSI)的妊娠患者。收集入院后 24 小时内的临床特征和实验室检查结果。根据标准程序对 OHSS 进行治疗,包括补液治疗、人血白蛋白、阿司匹林、低分子肝素和必要时行腹腔穿刺术。当清晨血细胞比容<40%且无明显临床相关症状(如腹胀、腹痛和呼吸困难)时,患者即可出院。同时,需要超声显示少量胸腔或腹腔积液以及生化异常恢复正常。采用 Spearman 相关分析评估血液相关参数与恢复时间的相关性。采用多元线性回归模型评估临床或实验室参数与恢复时间的关系。

结果

这些患者的中位恢复时间为 11 天。在 Spearman 相关检验中,白细胞、血红蛋白、血小板、血细胞比容、肌酐、凝血酶原时间(PT)、纤维蛋白原(Fib)、D-二聚体和纤维蛋白降解产物(FDPs)与恢复时间呈正相关。另一方面,白蛋白和凝血酶时间(TT)与恢复时间呈负相关。多元线性回归分析显示,多囊卵巢综合征(PCOS)、血红蛋白、血小板、白蛋白和 Fib 与 OHSS 患者的恢复时间显著相关(β=0.023,<0.001,β=0.007,<0.001,β=0.019,分别)。

结论

在 OHSS 妊娠患者中,PCOS 和低白蛋白血症与恢复时间显著延长相关。同时,血红蛋白、血小板和 Fib 水平升高时,恢复时间延长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ab/9240280/191450464bb8/fendo-13-870008-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ab/9240280/7ed89b536486/fendo-13-870008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ab/9240280/191450464bb8/fendo-13-870008-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ab/9240280/7ed89b536486/fendo-13-870008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ab/9240280/191450464bb8/fendo-13-870008-g002.jpg

相似文献

1
Predictive Factors for Recovery Time in Conceived Women Suffering From Moderate to Severe Ovarian Hyperstimulation Syndrome.预测中重度卵巢过度刺激综合征患者康复时间的相关因素。
Front Endocrinol (Lausanne). 2022 Jun 15;13:870008. doi: 10.3389/fendo.2022.870008. eCollection 2022.
2
Predictive factors for recovery time in patients suffering from severe OHSS.重度卵巢过度刺激综合征患者恢复时间的预测因素。
Reprod Biol Endocrinol. 2014 Jul 5;12:59. doi: 10.1186/1477-7827-12-59.
3
Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI.多囊卵巢综合征患者行体外受精/卵胞浆内单精子注射后卵巢过度刺激综合征严重程度的相关因素。
Front Endocrinol (Lausanne). 2021 Jan 19;11:615957. doi: 10.3389/fendo.2020.615957. eCollection 2020.
4
Volume expanders for the prevention of ovarian hyperstimulation syndrome.用于预防卵巢过度刺激综合征的扩容剂。
Cochrane Database Syst Rev. 2016 Aug 31;2016(8):CD001302. doi: 10.1002/14651858.CD001302.pub3.
5
[Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome].[血脂异常对多囊卵巢综合征患者体外受精/卵胞浆内单精子注射妊娠结局的影响]
Zhonghua Fu Chan Ke Za Zhi. 2018 Jun 25;53(6):402-408. doi: 10.3760/cma.j.issn.0529-567x.2018.06.008.
6
Predictive factors of early moderate/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model.非多囊卵巢综合征患者早期中重度卵巢过度刺激综合征的预测因素:一种统计模型
Arch Gynecol Obstet. 2015 Nov;292(5):1145-52. doi: 10.1007/s00404-015-3723-0. Epub 2015 Apr 29.
7
In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.多囊卵巢综合征女性体外成熟与使用促性腺激素释放激素拮抗剂的体外受精:治疗结局及卵巢过度刺激综合征发生率
Reprod Biomed Online. 2014 Nov;29(5):545-51. doi: 10.1016/j.rbmo.2014.07.019. Epub 2014 Aug 12.
8
[Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].[体外成熟与体外受精-胚胎移植治疗多囊卵巢综合征不孕女性的临床效果研究]
Zhonghua Fu Chan Ke Za Zhi. 2012 Apr;47(4):250-4.
9
Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.促性腺激素释放激素(GnRH)拮抗剂方案与GnRH激动剂方案中严重卵巢过度刺激综合征的风险:一项纳入1050个首次体外受精/卵胞浆内单精子注射周期的随机对照试验
Hum Reprod. 2016 Jun;31(6):1253-64. doi: 10.1093/humrep/dew051. Epub 2016 Apr 8.
10
Risk of Higher Blood Pressure in 3 to 6 Years Old Singleton Born From OHSS Patients Undergone With Fresh IVF/ICSI.新鲜 IVF/ICSI 后 OHSS 患者所生单胎 3-6 岁儿童高血压风险增加。
Front Endocrinol (Lausanne). 2022 Jul 5;13:817555. doi: 10.3389/fendo.2022.817555. eCollection 2022.

引用本文的文献

1
A stacked machine learning-based classification model for endometriosis and adenomyosis: a retrospective cohort study utilizing peripheral blood and coagulation markers.一种基于堆叠机器学习的子宫内膜异位症和子宫腺肌病分类模型:一项利用外周血和凝血标志物的回顾性队列研究。
Front Digit Health. 2024 Sep 10;6:1463419. doi: 10.3389/fdgth.2024.1463419. eCollection 2024.

本文引用的文献

1
Sequential E2 levels not ovarian maximal diameter estimates were correlated with outcome of cetrotide therapy for management of women at high-risk of ovarian hyperstimulation syndrome: a randomized controlled study.序贯雌二醇水平而非卵巢最大直径估计值与用于管理卵巢过度刺激综合征高危女性的西曲瑞克治疗结局相关:一项随机对照研究。
BMC Womens Health. 2017 Nov 13;17(1):108. doi: 10.1186/s12905-017-0466-z.
2
Severe ovarian hyperstimulation syndrome modifies early maternal serum beta-human chorionic gonadotropin kinetics, but obstetrical and neonatal outcomes are not impacted.重度卵巢过度刺激综合征会改变孕早期母体血清β-人绒毛膜促性腺激素的动力学,但产科和新生儿结局不受影响。
Fertil Steril. 2017 Oct;108(4):650-658.e2. doi: 10.1016/j.fertnstert.2017.07.1160. Epub 2017 Sep 11.
3
Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline.中重度卵巢过度刺激综合征的预防和治疗:指南。
Fertil Steril. 2016 Dec;106(7):1634-1647. doi: 10.1016/j.fertnstert.2016.08.048. Epub 2016 Sep 24.
4
Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles.卵巢过度刺激综合征:4894个连续辅助生殖技术治疗周期的临床报告
Reprod Biol Endocrinol. 2015 Jun 23;13:66. doi: 10.1186/s12958-015-0067-3.
5
Predictive factors of early moderate/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model.非多囊卵巢综合征患者早期中重度卵巢过度刺激综合征的预测因素:一种统计模型
Arch Gynecol Obstet. 2015 Nov;292(5):1145-52. doi: 10.1007/s00404-015-3723-0. Epub 2015 Apr 29.
6
Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention.卵巢过度刺激综合征:病理生理学、分期、预测和预防。
Ultrasound Obstet Gynecol. 2015 Apr;45(4):377-93. doi: 10.1002/uog.14684. Epub 2015 Mar 1.
7
Predictive factors for recovery time in patients suffering from severe OHSS.重度卵巢过度刺激综合征患者恢复时间的预测因素。
Reprod Biol Endocrinol. 2014 Jul 5;12:59. doi: 10.1186/1477-7827-12-59.
8
Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles.卵母细胞数量作为卵巢过度刺激综合征和活产预测指标的分析:256381 个体外受精周期。
Fertil Steril. 2014 Apr;101(4):967-73. doi: 10.1016/j.fertnstert.2013.12.026. Epub 2014 Jan 23.
9
Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment.预测和预防卵巢过度刺激综合征(OHSS):需要个体化而非标准化的治疗。
Reprod Biol Endocrinol. 2012 Apr 24;10:32. doi: 10.1186/1477-7827-10-32.
10
Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.血清抗苗勒管激素和窦卵泡计数作为 ART 周期中 OHSS 的预测标志物。
J Assist Reprod Genet. 2011 Dec;28(12):1197-203. doi: 10.1007/s10815-011-9627-4. Epub 2011 Sep 1.